Gossamer Bio Enters Noteholder Support Pact to Advance Convertible Notes Exchange

Gossamer Bio announced two key agreements to advance its convertible notes exchange. The company signed a Transaction Support Agreement with holders of about 75.2% of its Existing Convertible Notes, committing those investors to tender their notes by the early tender date and provide required consents. Separately, Gossamer executed voting agreements with Supporting Noteholders to ensure quorum and favorable votes on exchange-related stockholder proposals using New Shares issued in the offer. The arrangements include participation thresholds, transfer restrictions, and defined termination triggers, aiming to streamline execution of the exchange and related approvals.Agreement 1: Gossamer Bio Enters Noteholder Support Pact to Advance Convertible Notes ExchangeAgreement type: Transaction Support Agreement for Exchange Offer of Convertible NotesCounterparty: Supporting Noteholders of Existing Convertible NotesSigned / Effective: May 18 2026 / May 18 2026Duration / Termination: Until exchange offer settlement or earlier termination under agreement termsReason: Facilitate exchange offer and obtain required consentsAgreement 2: Gossamer Bio Secures Voting Agreements From Supporting Noteholders on Exchange-Related ProposalsAgreement type: Voting Agreements for New Shares From Exchange OfferCounterparty: Supporting NoteholdersSigned / Effective: May 18 2026 / May 18 2026Duration / Termination: From settlement until Special Meeting record date or two business days after settlementReason: Secure stockholder approval for exchange-related proposalsOriginal SEC Filing: Gossamer Bio, Inc. [ GOSS ] - 8-K - May. 18, 2026DisclaimerThis is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.